Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis

BACKGROUND AND OBJECTIVE: Pirfenidone is an oral antifibrotic agent that is approved in several countries for the treatment of idiopathic pulmonary fibrosis (IPF). We performed a comprehensive analysis of safety across four clinical trials evaluating pirfenidone in patients with IPF. METHODS: All pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respirology
Main Authors: Valeyre, Dominique, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, King, Talmadge E, Leff, Jonathan A, Noble, Paul W, Sahn, Steven A, du Bois, Roland M
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230393/
https://ncbi.nlm.nih.gov/pubmed/24836849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.12297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados